A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods

MLA

Marie-Louis Wronski, et al. “A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of 8-Week Intranasal Oxytocin Administration in Adults with Obesity: Rationale, Study Design, and Methods.” Contemporary Clinical Trials, vol. 122, June 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91803f9725c81b0b6e423c2fb3815264&authtype=sso&custid=ns315887.

APA

Marie-Louis Wronski, Franziska Plessow, Liya Kerem, Elisa Asanza, Michelle L. O’Donoghue, Fatima C. Stanford, Miriam A. Bredella, Martin Torriani, Alexander A. Soukas, Arvin Kheterpal, Kamryn T. Eddy, Tara M. Holmes, Thilo Deckersbach, Mark Vangel, Laura M. Holsen, & Elizabeth A. Lawson. (2022). A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods. Contemporary Clinical Trials, 122.

Chicago

Marie-Louis Wronski, Franziska Plessow, Liya Kerem, Elisa Asanza, Michelle L. O’Donoghue, Fatima C. Stanford, Miriam A. Bredella, et al. 2022. “A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of 8-Week Intranasal Oxytocin Administration in Adults with Obesity: Rationale, Study Design, and Methods.” Contemporary Clinical Trials 122 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91803f9725c81b0b6e423c2fb3815264&authtype=sso&custid=ns315887.